サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医薬品用ゼラチンの市場シェア、規模、動向、産業分析レポート：由来別（豚、牛皮、牛骨、魚、家禽）、機能別、最終用途別、地域別、セグメント予測、2023～2032年
市場調査レポート
商品コード
1287713

医薬品用ゼラチンの市場シェア、規模、動向、産業分析レポート：由来別（豚、牛皮、牛骨、魚、家禽）、機能別、最終用途別、地域別、セグメント予測、2023～2032年

Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医薬品用ゼラチンの市場シェア、規模、動向、産業分析レポート：由来別（豚、牛皮、牛骨、魚、家禽）、機能別、最終用途別、地域別、セグメント予測、2023～2032年
出版日: 2023年04月01日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの新しい調査によると、世界の医薬品用ゼラチンの市場規模は2032年までに21億7,000万米ドルに達すると予想されています。本レポートでは、現在の市場力学を詳細に把握し、将来の市場成長に関する分析を提供しています。

医薬品用ゼラチンは、動物の皮膚や骨、白色結合組織に含まれるコラーゲンを部分的に加水分解して得られる、高分子量の繊細な水溶性・無色・半透明の物質です。無毒で吸収性が高く、様々な医薬用途に広く利用されています。ゼラチンは、一般的に医薬品の懸濁液を安定化させ、カプセルを製造するための懸濁剤として使用されています。さらに、ゼラチンは優れたタンパク質源であり、血漿の代用品として使用することができます。

外科手術では、吸収性フィルムやスポンジにゼラチンが含まれています。ゼラチン市場は、栄養補助食品および製薬業界における医薬品製造のためのゼラチン使用の増加、栄養豊富な食品の重要性に対する意識の高まり、高齢者人口の拡大によって牽引されています。しかし、カプセルの外装に多用されるゼラチンのコストが高いことや、代替成分の入手が可能であることが、市場の成長を妨げています。さらに、食品における栄養強化の意識の高まりは、この市場の将来の成長機会となっています。

市場参入企業が最先端技術を駆使して特徴的なゼラチンカプセルの殻を作る努力を強化しているため、市場拡大の機会がいくつか存在します。例えば、デジタルヘルス企業のetectRx, Inc.は、ヒト免疫不全ウイルス（HIV）を扱いながら、薬物オピオイド使用者の抗レトロウイルス治療の観察を追跡する研究を実施しています。MyTPillプロジェクトでは、ハードゼラチンのカプセルに、摂取可能かつウェアラブルリーダーの無線検出器を組み合わせた「システムID-Cap」を用いて、患者のアドヒアランスを評価する予定です。このような前例のない取り組みにより、ハードゼラチンカプセル（ID-Cap）の製造におけるゼラチンの使用量が増加し、市場成長が加速されます。

COVID-19では、パンデミック規制によりゼラチンベースの製品やカプセルの輸出入が停止されたため、ゼラチンの生産とサプライチェーンに大きな影響を与えました。注目すべきは、ゼラチンがCOVID-19の治療に重要な役割を果たすことが判明したことです。例えば、2022年5月に発表されたPubMedの研究では、ドラッグデリバリーにゼラチンを加えることでタンパク質の安定化がかなり改善され、ネブライゼーション後の活性タンパク質分画が向上し、薬の投与量を減らすことが明らかになりました。パンデミック後の時代には、製品発売の増加、医薬品グレードのゼラチンの需要増加、ゼラチンベースの製品の研究開発の増加により、市場の成長が期待されます。

レポートハイライト

  • 医薬品用ゼラチン市場は、ハードカプセル、ソフトジェルカプセル、錠剤、吸収性止血材、その他と、さまざまな用途に分類されます。医薬品用ゼラチン市場では、予測期間中にソフトゲルカプセル分野が最も高い成長を遂げると予想されています。
  • 豚由来が市場シェアを独占しており、主なセグメントは豚、牛皮、牛骨、魚、家禽です。豚由来原料を使用すること別迅速な製造サイクルと費用対効果の高さが、このセグメントの成長に寄与する主な要因の一つとなっています。
  • 北米地域は、医薬品用ゼラチン市場において重要な位置を占めています。この地域の市場成長は、確立された製薬産業の存在、研究開発活動の活発化、医薬品需要の高まりに起因していると考えられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の医薬品用ゼラチン市場に関する洞察

  • 医薬品用ゼラチン市場- 最終用途のスナップショット
  • 医薬品用ゼラチン市場力学
    • 促進要因と機会
      • 健康的なライフスタイルを選択する需要の高まり
      • コラーゲン摂取の好み
    • 抑制要因と課題
      • ゼラチンのコストが高い
  • PESTEL分析
  • 医薬品用ゼラチン市場の最終動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の医薬品用ゼラチン市場、由来別

  • 主な調査結果
  • イントロダクション
  • 豚
  • 牛皮
  • 牛骨
  • 魚
  • 家禽

第6章 世界の医薬品用ゼラチン市場、機能別

  • 主な調査結果
  • イントロダクション
  • 安定化
  • 増粘
  • ゲル化

第7章 世界の医薬品用ゼラチン市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • ハードカプセル
  • ソフトカプセル
  • 錠剤
  • 吸収性止血材

第8章 世界の医薬品用ゼラチン市場、地域別

  • 主な調査結果
  • イントロダクション
    • 医薬品用ゼラチン市場評価、地域別、2019-2032年
  • 医薬品用ゼラチン市場-北米
    • 北米：医薬品用ゼラチン市場、由来別、2019-2032年
    • 北米：医薬品用ゼラチン市場、最終用途別、2019-2032年
    • 北米：医薬品用ゼラチン市場、機能別、2019-2032年
    • 医薬品用ゼラチン市場- 米国
    • 医薬品用ゼラチン市場- カナダ
  • 医薬品用ゼラチン市場- 欧州
    • 欧州：医薬品用ゼラチン市場、由来別、2019-2032
    • 欧州：医薬品用ゼラチン市場、最終用途別、2019-2032
    • 欧州：医薬品用ゼラチン市場、機能別、2019～2032年
    • 医薬品用ゼラチン市場- 英国
    • 医薬品用ゼラチン市場- フランス
    • 医薬品用ゼラチン市場- ドイツ
    • 医薬品用ゼラチン市場- イタリア
    • 医薬品用ゼラチン市場- スペイン
    • 医薬品用ゼラチン市場- オランダ
    • 医薬品用ゼラチン市場- ロシア
  • 医薬品用ゼラチン市場- アジア太平洋
    • アジア太平洋：医薬品用ゼラチン市場、由来別、2019～2032年
    • アジア太平洋：医薬品用ゼラチン市場、最終用途別、2019-2032年
    • アジア太平洋：医薬品用ゼラチン市場、機能別、2019～2032年
    • 医薬品用ゼラチン市場- 中国
    • 医薬品用ゼラチン市場- インド
    • 医薬品用ゼラチン市場- マレーシア
    • 医薬品用ゼラチン市場- 日本
    • 医薬品用ゼラチン市場- インドネシア
    • 医薬品用ゼラチン市場- 韓国
  • 医薬品用ゼラチン市場-中東・アフリカ
    • 中東・アフリカ：医薬品用ゼラチン市場、由来別、2019-2032年
    • 中東・アフリカ：医薬品用ゼラチン市場、最終用途別、2019-2032
    • 中東・アフリカ：医薬品用ゼラチン市場、機能別、2019-2032年
    • 医薬品用ゼラチン市場- サウジアラビア
    • 医薬品用ゼラチン市場- アラブ首長国連邦
    • 医薬品用ゼラチン市場- イスラエル
    • 医薬品用ゼラチン市場- 南アフリカ
  • 医薬品用ゼラチン市場-ラテンアメリカ
    • ラテンアメリカ：医薬品用ゼラチン市場、由来別、2019-2032年
    • ラテンアメリカ：医薬品用ゼラチン市場、最終用途別、2019-2032
    • ラテンアメリカ：医薬品用ゼラチン市場、機能別、2019-2032年
    • 医薬品用ゼラチン市場- メキシコ
    • 医薬品用ゼラチン市場- ブラジル
    • 医薬品用ゼラチン市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/協定/公開

第10章 企業プロファイル

  • Tessenderlo Group
  • Rousselot
  • Nitta Gelatin Inc
  • Gelita AG
  • Catelent Inc
  • Capsugel
  • Norland Products Inc
  • Roxlor llc
  • Trobas Pharmaceutical Gelatine B.V
  • Sterling Gelatin
  • Aspire Pharmaceuticals
  • Junca Gelatines
  • Gelco International
  • Lapi Gelatine S.p.a
図表

List of Tables

  • Table 1 Global Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 2 Global Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 3 Global Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Pharmaceutical Gelatin Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 6 North America: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 7 North America: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 9 U.S.: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 10 U.S.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 12 Canada: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 13 Canada: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 15 Europe: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 16 Europe: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 18 UK: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 19 UK: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 21 France: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 22 France: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 24 Germany: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 25 Germany: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 27 Italy: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 28 Italy: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 30 Spain: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 31 Spain: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 36 Russia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 37 Russia: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 42 China: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 43 China: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 45 India: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 46 India: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 51 Japan: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 52 Japan: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 57 South Korea: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 58 South Korea: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 66 UAE: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 67 UAE: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 69 Israel: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 70 Israel: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 72 South Africa: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 73 South Africa: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 75 Latin America: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 76 Latin America: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 78 Mexico: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 79 Mexico: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 81 Brazil: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 82 Brazil: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • Table 84 Argentina: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • Table 85 Argentina: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Pharmaceutical Gelatin Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Function
  • Figure 7. Global Pharmaceutical Gelatin Market, by Function, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Source
  • Figure 9. Global Pharmaceutical Gelatin Market, by Source, 2021 & 2030 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Pharmaceutical Gelatin Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 12. Pharmaceutical Gelatin Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Pharmaceutical Gelatin Market
目次
Product Code: PM3183

The global pharmaceutical gelatin market size is expected to reach USD 2.17 billion by 2032, according to a new study by Polaris Market Research. The report "Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Surce (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2022 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical gelatin is a high molecular weight, delicate, water-soluble, colorless, and translucent substance obtained from the partial hydrolysis of collagen found in animal skin, bones, and white connective tissues. It is a non-toxic and absorbable substance extensively utilized in various pharmaceutical applications. Gelatin is commonly used as a suspending agent to stabilize pharmaceutical suspensions and produce capsules. Furthermore, it is an excellent source of protein and can be used as a substitute for plasma.

In surgical procedures, absorbable film and sponges contain gelatin. The gelatin market is driven by the increasing use of gelatin in the nutraceutical and pharmaceutical industries for manufacturing drugs, growing awareness of the importance of nutrition-rich foods, and the expanding senior population. However, the high cost of gelatin, which is heavily used in the outer covering of capsules, and the availability of substitute components hinder the market growth. Furthermore, the rising awareness of nutrition fortification in food presents an opportunity for future growth in this market.

Several opportunities for market expansion exist due to the major market participants enhanced efforts to create distinctive gelatin capsule shells employing cutting-edge technology. For example, a digital health company, etectRx, Inc., has been conducting studies to track medication opioid users' observation with antiretroviral treatment while handling human immunodeficiency virus (HIV). In the "MyTPill" project, patient adherence will be evaluated using the System ID-Cap, which comprises a capsule of hard gelatin with the wireless detector of an ingestible and a wearable reader. These unprecedented steps will increase the use of gelatin in producing hard gelatin capsules (ID-Cap), accelerating market growth.

The production and supply chain of gelatin were significantly affected by COVID-19 as the import and export of gelatin-based products and capsules were suspended due to pandemic restrictions. Notably, gelatin was found to play a vital role in COVID-19 treatment. For example, a PubMed study published in May 2022 revealed that adding gelatin to drug delivery considerably improves protein stabilization and enhances the active protein fractions after nebulization, thus reducing medication dosages. In the post-pandemic era, the market is expected to experience growth due to increased product launches, higher demand for pharmaceutical-grade gelatin, and increased research and development in gelatin-based products.

Report Highlights

  • The pharmaceutical gelatin market is categorized into various applications: hard capsules, soft gel capsules, tablets, absorbable hemostats, and others. The soft gel capsules segment is expected to witness the highest growth during the forecast period in the pharmaceutical gelatin market.
  • Porcine sources dominate the market share, with the main segments being pork, bovine skin, bone, marine, and poultry. The rapid manufacturing cycle and cost-effectiveness of using porcine sources are among the primary factors contributing to the growth of this segment.
  • The North American region holds a significant position in the pharmaceutical gelatin market. The market growth in the area can be attributed to the presence of a well-established pharmaceutical industry, increasing research and development activities, and rising demand for pharmaceutical products.

Polaris Market Research has segmented the Pharmaceutical Gelatin Market report based on source, function, end-use, and region:

Pharmaceutical Gelatin Market, Source Outlook (Revenue - USD Billion, 2019 - 2032)

  • Porcine
  • Bovine Skin
  • Bovine Bone
  • Fish
  • Poultry

Pharmaceutical Gelatin Market, Function Outlook (Revenue - USD Billion, 2019 - 2032)

  • Stabilizing
  • Thickening
  • Gelling

Pharmaceutical Gelatin Market, End-Use Outlook (Revenue - USD Billion, 2019- 2032)

  • Hard Capsule
  • Soft Capsule
  • Tablet
  • Absorbable Hemostat

Pharmaceutical Gelatin Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pharmaceutical Gelatin Market Insights

  • 4.1. Pharmaceutical Gelatin Market - End-Use Snapshot
  • 4.2. Pharmaceutical Gelatin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand of Choosing Healthy Lifestyle
      • 4.2.1.2. Preference of Collagen Consumption
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Gelatins
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Pharmaceutical Gelatin Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pharmaceutical Gelatin Market, by Source

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
  • 5.3. Porcine
    • 5.3.1. Global Pharmaceutical Gelatin Market, by Porcine, by Region, 2019-2032 (USD Billion)
  • 5.4. Bovine Skin
    • 5.4.1. Global Pharmaceutical Gelatin Market, by Bovine Skin, by Region, 2019-2032 (USD Billion)
  • 5.5. Bovine Bone
    • 5.5.1. Global Pharmaceutical Gelatin Market, by Bovine Bone, by Region, 2019-2032 (USD Billion)
  • 5.6. Fish
    • 5.6.1. Global Pharmaceutical Gelatin Market, by Fish, by Region, 2019-2032 (USD Billion)
  • 5.7. Poultry
    • 5.7.1. Global Pharmaceutical Gelatin Market, by Poultry, by Region, 2019-2032 (USD Billion)

6. Global Pharmaceutical Gelatin Market, by Function

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • 6.3. Stabilizing
    • 6.3.1. Global Pharmaceutical Gelatin Market, by Stabilizing, by Region, 2019-2032 (USD Billion)
  • 6.4. Thickening
    • 6.4.1. Global Pharmaceutical Gelatin Market, by Thickening, by Region, 2019-2032 (USD Billion)
  • 6.5. Gelling
    • 6.5.1. Global Pharmaceutical Gelatin Market, by Gelling, by Region, 2019-2032 (USD Billion)

7. Global Pharmaceutical Gelatin Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3. Hard Capsule
    • 7.3.1. Global Pharmaceutical Gelatin Market, by Hard Capsule, By Region, 2019-2032 (USD Billion)
  • 7.4. Soft Capsule
    • 7.4.1. Global Pharmaceutical Gelatin Market, by Soft Capsule, By Region, 2019-2032 (USD Billion)
  • 7.5. Tablet
    • 7.5.1. Global Pharmaceutical Gelatin Market, by Tablet, By Region, 2019-2032 (USD Billion)
  • 7.6. Absorbable Hemostat
    • 7.6.1. Global Pharmaceutical Gelatin Market, by Absorbable Hemostat, By Region, 2019-2032 (USD Billion)

8. Global Pharmaceutical Gelatin Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Pharmaceutical Gelatin Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Pharmaceutical Gelatin Market - North America
    • 8.3.1. North America: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
    • 8.3.2. North America: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.3.4. Pharmaceutical Gelatin Market - U.S.
      • 8.3.4.1. U.S.: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.3.5. Pharmaceutical Gelatin Market - Canada
      • 8.3.5.1. Canada: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • 8.4. Pharmaceutical Gelatin Market - Europe
    • 8.4.1. Europe: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.4. Pharmaceutical Gelatin Market - UK
      • 8.4.4.1. UK: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.5. Pharmaceutical Gelatin Market - France
      • 8.4.5.1. France: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.6. Pharmaceutical Gelatin Market - Germany
      • 8.4.6.1. Germany: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.7. Pharmaceutical Gelatin Market - Italy
      • 8.4.7.1. Italy: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.8. Pharmaceutical Gelatin Market - Spain
      • 8.4.8.1. Spain: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.9. Pharmaceutical Gelatin Market - Netherlands
      • 8.4.9.1. Netherlands: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.4.10. Pharmaceutical Gelatin Market - Russia
      • 8.4.10.1. Russia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • 8.5. Pharmaceutical Gelatin Market - Asia Pacific
    • 8.5.1. Asia Pacific: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.4. Pharmaceutical Gelatin Market - China
      • 8.5.4.1. China: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.5. Pharmaceutical Gelatin Market - India
      • 8.5.5.1. India: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.6. Pharmaceutical Gelatin Market - Malaysia
      • 8.5.6.1. Malaysia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.7. Pharmaceutical Gelatin Market - Japan
      • 8.5.7.1. Japan: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.8. Pharmaceutical Gelatin Market - Indonesia
      • 8.5.8.1. Indonesia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.5.9. Pharmaceutical Gelatin Market - South Korea
      • 8.5.9.1. South Korea: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • 8.6. Pharmaceutical Gelatin Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.6.4. Pharmaceutical Gelatin Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.6.5. Pharmaceutical Gelatin Market - UAE
      • 8.6.5.1. UAE: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.6.6. Pharmaceutical Gelatin Market - Israel
      • 8.6.6.1. Israel: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.6.7. Pharmaceutical Gelatin Market - South Africa
      • 8.6.7.1. South Africa: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
  • 8.7. Pharmaceutical Gelatin Market - Latin America
    • 8.7.1. Latin America: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.7.4. Pharmaceutical Gelatin Market - Mexico
      • 8.7.4.1. Mexico: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.7.5. Pharmaceutical Gelatin Market - Brazil
      • 8.7.5.1. Brazil: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)
    • 8.7.6. Pharmaceutical Gelatin Market - Argentina
      • 8.7.6.1. Argentina: Pharmaceutical Gelatin Market, by Source, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Pharmaceutical Gelatin Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Pharmaceutical Gelatin Market, by Function, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Tessenderlo Group
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Function Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Rousselot
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Function Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Nitta Gelatin Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Function Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Gelita AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Function Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Catelent Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Function Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Capsugel
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Function Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Norland Products Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Function Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Roxlor llc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Function Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Trobas Pharmaceutical Gelatine B.V
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Function Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sterling Gelatin
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Function Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Aspire Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Function Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Junca Gelatines
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Function Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Gelco International
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Function Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Lapi Gelatine S.p.a
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Function Benchmarking
    • 10.14.4. Recent Development